Related Experiment Videos
Binding of topo I to PARP I - antibody immunocomplex
Insights
Poly (ADP-ribose) polymerase I (PARP I) regulates gene expression by interacting with Topoisomerase I (Topo I). This interaction controls DNA readability without requiring DNA damage.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Poly (ADP-ribose) polymerase I (PARP I) is known for its role in DNA damage recognition.
- The full physiological function of PARP I, a highly abundant nuclear protein, is likely more extensive than its role in DNA repair.
Purpose of the Study:
- To demonstrate that PARP I regulates significant cellular processes beyond DNA damage response.
- To validate the interaction and functional significance of PARP I and Topoisomerase I (Topo I) under physiological conditions.
Main Methods:
- Quantitative binding assays using a PARP I-antibody complex to detect Topo I.
- In vitro experiments demonstrating Topo I activation by PARP I association.
Main Results:
- Demonstrated the quantitative binding of Topo I to a PARP I-antibody complex, confirming in vivo interaction.
- Showcased PARP I's ability to regulate gene expression via Topo I modulation without induced DNA damage.
Conclusions:
- PARP I's colligative action significantly regulates gene expression by controlling DNA readability.
- The interaction between PARP I and Topo I represents a key mechanism for regulating genomic DNA accessibility and gene expression.
Abstract:
It is frequently quoted in the literature that the cellular role of PARP I is its participation in the recognition of single strand breaks of genomic DNA (l.c.1). Although there is little doubt that PARP I can be made to respond powerfully as an factor in the recognition of DNA damage, it seems unlikely that this auxilliary, or telelogically defined, role of this highly abundant nuclear protein exhausts its physiologic cellular function. We have reported that Topo I is greatly activated by its association with PARP I (J Mol Med 5: 533-540, 2000). Translation of this in vitro model experiments to physiologic conditions was accomplished by the demonstration of the quantitative binding of Topo I to a PARP I - antibody complex, as reported here. This experiment demonstrates for the first time that the colligative action of PARP I can regulate a highly significant cellular process, the control of readability of genomic DNA, i.e., gene expression, without the artificiality of induced DNA damage.